Eberlein W - Search Results

1

BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.

Doods H, Gaida W, Wieland HA, Dollinger H, Schnorrenberg G, Esser F, Engel W, Eberlein W, Rudolf K. Doods H, et al. Among authors: eberlein w. Eur J Pharmacol. 1999 Nov 19;384(2-3):R3-5. doi: 10.1016/s0014-2999(99)00650-0. Eur J Pharmacol. 1999. PMID: 10611450

2

Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.

Doods HN, Wienen W, Entzeroth M, Rudolf K, Eberlein W, Engel W, Wieland HA. Doods HN, et al. Among authors: eberlein w. J Pharmacol Exp Ther. 1995 Oct;275(1):136-42. J Pharmacol Exp Ther. 1995. PMID: 7562541

3

Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.

Wieland HA, Willim KD, Entzeroth M, Wienen W, Rudolf K, Eberlein W, Engel W, Doods HN. Wieland HA, et al. Among authors: eberlein w. J Pharmacol Exp Ther. 1995 Oct;275(1):143-9. J Pharmacol Exp Ther. 1995. PMID: 7562543

4

Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226.

Entzeroth M, Braunger H, Eberlein W, Engel W, Rudolf K, Wienen W, Wieland HA, Willim KD, Doods HN. Entzeroth M, et al. Among authors: eberlein w. Eur J Pharmacol. 1995 May 24;278(3):239-42. doi: 10.1016/0014-2999(95)00161-d. Eur J Pharmacol. 1995. PMID: 7589160

5

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.

Rudolf K, Eberlein W, Engel W, Wieland HA, Willim KD, Entzeroth M, Wienen W, Beck-Sickinger AG, Doods HN. Rudolf K, et al. Among authors: eberlein w. Eur J Pharmacol. 1994 Dec 27;271(2-3):R11-3. doi: 10.1016/0014-2999(94)90822-2. Eur J Pharmacol. 1994. PMID: 7705422

6

Characterization of BIBN 99: a lipophilic and selective muscarinic M2 receptor antagonist.

Doods H, Entzeroth M, Ziegler H, Schiavi G, Engel W, Mihm G, Rudolf K, Eberlein W. Doods H, et al. Among authors: eberlein w. Eur J Pharmacol. 1993 Sep 21;242(1):23-30. doi: 10.1016/0014-2999(93)90005-3. Eur J Pharmacol. 1993. PMID: 8223934

7

BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties.

Doods HN, Wieland HA, Engel W, Eberlein W, Willim KD, Entzeroth M, Wienen W, Rudolf K. Doods HN, et al. Among authors: eberlein w. Regul Pept. 1996 Aug 27;65(1):71-7. doi: 10.1016/0167-0115(96)00074-2. Regul Pept. 1996. PMID: 8876038 Review.

8

Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents.

Wieland HA, Engel W, Eberlein W, Rudolf K, Doods HN. Wieland HA, et al. Among authors: eberlein w. Br J Pharmacol. 1998 Oct;125(3):549-55. doi: 10.1038/sj.bjp.0702084. Br J Pharmacol. 1998. PMID: 9806339 Free PMC article.

9

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.

Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W, Eberlein W. Doods H, et al. Among authors: eberlein w. Br J Pharmacol. 2000 Feb;129(3):420-3. doi: 10.1038/sj.bjp.0703110. Br J Pharmacol. 2000. PMID: 10711339 Free PMC article.

10

Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor.

Wu D, Eberlein W, Rudolf K, Engel W, Hallermayer G, Doods H. Wu D, et al. Among authors: eberlein w. Eur J Pharmacol. 2000 Jul 21;400(2-3):313-9. doi: 10.1016/s0014-2999(00)00407-6. Eur J Pharmacol. 2000. PMID: 10988349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters